OMIA:000683-89462 : Muscular hypertrophy (double muscling) in Bubalus bubalis (water buffalo) |
In other species: rock pigeon , chicken , dog , pig , taurine cattle , goat , sheep , rabbit , Japanese quail , yellow catfish
Categories: Muscle phene
Possibly relevant human trait(s) and/or gene(s)s (MIM numbers): 601788 (gene) , 614160 (trait)
Links to MONDO diseases:
Mendelian trait/disorder: yes
Considered a defect: no
Key variant known: no
Cross-species summary: Abnormal increase in muscular tissue caused entirely by enlargement of existing cells (in contrast to muscular hyperplasia, in which the abnormal increase in muscular tissue is due to the formation and growth of new, normal muscle cells)
Species-specific description: Dua et al. (2023) produced "myostatin (MSTN) gene-edited embryos of the Murrah buffalo using the CRISPR/Cas9 system and SCNT. ... This work establishes the technical foundation for generation of genome-edited cloned embryos in the buffalo." This study involves genetically modified organisms (GMO).
Genetic engineering:
Yes - variants have been created artificially, e.g. by genetic engineering or gene editing
Have human generated variants been created, e.g. through genetic engineering and gene editing
Associated gene:
| Symbol | Description | Species | Chr | Location | OMIA gene details page | Other Links |
|---|---|---|---|---|---|---|
| MSTN | myostatin | Bubalus bubalis | 2 | NC_059158.1 (58423897..58428995) | MSTN | Homologene, Ensembl , NCBI gene |
Cite this entry
Nicholas, F. W., Tammen, I., & Sydney Informatics Hub. (2023). OMIA:000683-89462: Online Mendelian Inheritance in Animals (OMIA) [dataset]. https://omia.org/. https://doi.org/10.25910/2AMR-PV70
Reference
| 2023 | Dua, S., Bansal, S., Gautam, D., Jose, B., Singh, P., Singh, M.K., De, S., Kumar, D., Yadav, P.S., Kues, W., Selokar, N.L. : |
| Production of MSTN gene-edited embryos of buffalo using the CRISPR/Cas9 system and SCNT. Cell Reprogram 25:121-127, 2023. Pubmed reference: 37042654. DOI: 10.1089/cell.2023.0003. |
Edit History
- Created by Imke Tammen2 on 23 Apr 2023
- Changed by Imke Tammen2 on 12 Dec 2023